Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 10;12(10):e0185489.
doi: 10.1371/journal.pone.0185489. eCollection 2017.

Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?

Affiliations

Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?

Carolin Gramsch et al. PLoS One. .

Abstract

Background: Visualisation of nigrosome 1, a substructure of the healthy substantia nigra, was restricted in susceptibility weighted MR imaging in almost all patients with Parkinson's disease studied so far. The purpose of this study was to determine the degree of visibility of this substructure in subjects without Parkinson's disease and to examine the potential link between increasing brain iron accumulation with age and its detectability.

Methods: In 46 subjects (21 women, 25 men; 19 to 75 y; mean age: 44.5; SD: 15.6) examined with susceptibility weighted MR imaging at 7T visibility of nigrosome 1 was rated and classified. We assessed differences related to age and to signal intensities in the substantia nigra, red nucleus and putamen as correlates of the individual iron concentration.

Results: In 93% nigrosome 1was at least unilaterally clearly present. In 24% at least one-sided limited visibility was observed. Using predefined classification criteria the specificity of the visibility across all age groups reached approximately 94%. We found no correlation with increasing iron concentrations with age.

Conclusion: Aging with a related increase in iron concentration probably does not affect the visibility of nigrosome 1 at 7T SWI MRI. Our results support the role of this feature as a future differential diagnostic tool but further large-scale prospective studies are needed to better define the extent of a "limited visibility" to which an individual can be considered healthy.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. SWI 7T MRI of the midbrain and the surrounding structures.
CSF: cerebrospinal fluid, Pu: putamen, SN: substantia nigra, NR: Nucleus ruber, N1: Nigrosome 1.
Fig 2
Fig 2. SWI 7T MRI of the SN.
a1, b1: examples for a midbrain rated as bilaterally clearly visible nigrosome 1 (Group I); a2, b2: highlighted nigrosome 1 in the same subjects; c: ROI positioning in the SN, putamen, red nucleus and CSF of the ventricular system.
Fig 3
Fig 3. Midbrains rated as “limited visibility”.
a: unilateral “limited visibility on the right side rated as 1; b: bilateral “limited visibility” on each side rated as 1, c: bilateral not visible nigrosome 1.
Fig 4
Fig 4. Column scatter plots of the SIs of all subjects within the respective nuclei and age groups.
SIs of subjects rated as “limited visibility” are marked by size and shape: medium size = “limited visibility” with at least a unilaterally rated 1, biggest size = containing a rating as 0 “not visible nigrosome 1”.

Similar articles

Cited by

References

    1. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol. 2000; 57[3]:369–72. - PubMed
    1. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K et al. Natural history of progressive supranuclear palsy [Steele-Richardson-Olszewski syndrome] and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996; 60[6]:615–20. - PMC - PubMed
    1. Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, Seppi K. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis. 2010; 7[5]:300–18. doi: 10.1159/000314495 - DOI - PubMed
    1. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol. 2006; 5[1]:75–86. doi: 10.1016/S1474-4422(05)70285-4 - DOI - PubMed
    1. Seppi K, Yekhlef F, Diem A, Luginger WE, Mueller J, Tison F et al. Progression of parkinsonism in multiple system atrophy. J Neurol. 2005; 252[1]:91–6. doi: 10.1007/s00415-005-0617-2 - DOI - PubMed